Su-Jin Park

Title: The Innovative Contributions of Su-Jin Park

Introduction

Su-Jin Park is a prominent inventor based in Seongnam-si, South Korea. She has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of five patents to her name, her work has had a substantial impact on public health.

Latest Patents

One of Su-Jin Park's latest patents is a polyvalent pneumococcal polysaccharide-protein conjugate composition. This immunogenic composition comprises 15 different polysaccharide-protein conjugates. Each conjugate includes a capsular polysaccharide prepared from different serotypes, specifically serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 9N, 9V, 14, 18C, 19A, 19F, and 23F. The formulation of this immunogenic composition into a vaccine, which includes an aluminum-based adjuvant, enhances its application range concerning pneumococcal diseases in infants and children.

Career Highlights

Throughout her career, Su-Jin Park has worked with notable companies such as SK Chemicals Co., Ltd. and Dongwoo Syntech Co., Ltd. Her experience in these organizations has allowed her to develop and refine her innovative ideas in vaccine technology.

Collaborations

Su-Jin Park has collaborated with esteemed colleagues, including Jin-Hwan Shin and Mahn-Hoon Park. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Su-Jin Park's innovative work in vaccine development showcases her dedication to improving public health. Her contributions through her patents and collaborations highlight her importance in the field of immunology.